Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Apellis Pharmaceuticals, Inc.
Scientific Title
A Phase III, Randomized, Multi-Center, Open-Label, Active-Comparator Controlled Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)